Emcure Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Emcure Pharma	JB Chem & Pharma	Ajanta Pharma
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	1.4 %	10.1 %	7.5 %
US DMF Filings	102.0 .	n/a	n/a
R&D as a % of Total Sales	3.9 %	1.35 %	5.0 %
Financials
5 yr Average ROE	20.81 %	19.49 %	21.63 %
5yr average Equity Multiplier	2.6	1.52	1.32
5yr Average Asset Turnover Ratio	0.93	0.77	0.84
5yr Avg Net Profit Margin	8.56 %	16.71 %	19.77 %
Price to Book	6.51	8.45	8.54
P/E	34.84	49.53	36.62
5yr Avg Cash Conversion Cycle	-8.5 Days	7.58 Days	-102.34 Days
Inventory Days	82.11 Days	50.96 Days	55.16 Days
Days Receivable	87.83 Days	72.72 Days	49.8 Days
Days Payable	177.06 Days	94.5 Days	195.69 Days
5yr Average Interest Coverage Ratio	5.19	76.53	108.5
5yr Avg ROCE	27.53 %	23.05 %	27.48 %
5yr Avg Operating Profit Margin	19.97 %	24.73 %	27.65 %
5 yr average Debt to Equity	0.76	0.07	0.0
5yr CAGR Net Profit	11.68 %	12.98 %	7.08 %
5yr Average Return on Assets	7.99 %	12.98 %	16.51 %
Shareholdings
Promoter Holding	77.87 %	48.8 %	66.25 %
Share Pledged by Promoters	0.04 %	0.0	17.94 %
Change in Promoter Holding (3 Yrs)	-0.21 %	-5.13 %	0.14 %
Change in Mutual Fund Holding (3 Yrs)	1.64 %	2.83 %	1.45 %

Business

	Emcure Pharma	JB Chem & Pharma	Ajanta Pharma
Product Wise Break-Up	Product Wise Break-Up Formulations 95.73 API`s 4.27 CDMO 0 API 0 Formulation exported 0 Domestic formulation 0 Pharmaceutical products 0	Product Wise Break-Up Formulations 28.73 Active Pharmaceutical Ingredient (API) 1.97 Domestic Formulations 58.22 Formulations 0 Pharmaceutical products 0 Contract Manufacturing 10.99 API`s 0 Others 0.09	Product Wise Break-Up Formulation exported 0 API 0 Domestic formulation 0 Formulations 0 Pharmaceutical 100.0 CDMO 0 API`s 0
Product Wise Break-Up	Product Wise Break-Up Formulations 95.73 API`s 4.27 CDMO 0 API 0 Formulation exported 0 Domestic formulation 0 Pharmaceutical products 0	Product Wise Break-Up Formulations 28.73 Active Pharmaceutical Ingredient (API) 1.97 Domestic Formulations 58.22 Formulations 0 Pharmaceutical products 0 Contract Manufacturing 10.99 API`s 0 Others 0.09	Product Wise Break-Up Formulation exported 0 API 0 Domestic formulation 0 Formulations 0 Pharmaceutical 100.0 CDMO 0 API`s 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Cardiovascular 20.8 Gynecology 18.5 Anti-infectives 12.8 Pain and analgesics 7.1 Vitamins, minerals and nutrients 6.7 Blood-related 5.9 Oncology/Anti-neoplastics 5.4 Respiratory 5.1 HIV antivirals 4.5 Gastrointestinal 3.7 Anti-diabetic 2.9 Neurology/CNS 1.6 Hormones 0 Others 5.0	-	Therapeutic Area Wise Break-Up - Domestic Anti-infectives 0 Anti-diabetic 0 Pain and analgesics 0 Respiratory 0 Vitamins, minerals and nutrients 0 Oncology/Anti-neoplastics 0 Gynecology 0 Blood-related 0 Gastrointestinal 0 Neurology/CNS 0 Cardiovascular 0 Hormones 0 HIV antivirals 0 Others 100
Location Wise Break-Up	Location Wise Break-Up India 43.38 Other continents 20.19 Europe 19.64 North America 16.8 Rest of the World 0 Russia 0 South Africa 0 USA 0 Asia 0 Africa 0	Location Wise Break-Up Russia 0 Other continents 0 Africa 0 USA 0 South Africa 0 Europe 0 Asia 0 North America 0 Rest of the World 42.09 India 57.91	Location Wise Break-Up Russia 0 Other continents 0 Africa 16.28 USA 35.74 South Africa 0 Europe 0 Asia Pacific 19.39 North America 0 Rest of the World 0 India 28.59
Acute vs Chronic	Acute vs Chronic Chronic 52.87 Acute therapy 47.13	-	-
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise India 97.98 North America 1.24 Other continents 0.78 Europe 0	-	-

Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE